Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines - PubMed (original) (raw)
. 2011 Apr 21;30(16):1963-8.
doi: 10.1038/onc.2010.559. Epub 2010 Dec 6.
Affiliations
- PMID: 21132008
- DOI: 10.1038/onc.2010.559
Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines
H Zhang et al. Oncogene. 2011.
Abstract
Non-small-cell lung cancer (NSCLC) is the most deadly type of cancer in the United States and worldwide. Although new therapy is available, the survival rate of NSCLC patients remains low. One hallmark of cancer cells is defects in the apoptotic cell death program. In this study, we investigate the role of B-cell lymphoma 2 (Bcl-2) family members Bcl-2, Bcl-x(L) and Mcl-1, known to regulate cell survival and death, in a panel of fourteen NSCLC cell lines. NSCLC cell lines express high levels of Mcl-1 and Bcl-x(L), but not Bcl-2. Silencing the expression of Mcl-1 with small interfering RNA (siRNA) oligonucleotides potently killed a subgroup of NSCLC cell lines. In contrast, Bcl-x(L) siRNA had no effect in these lines unless Mcl-1 siRNA was also introduced. Interestingly, high MCL1 to BCL-xl messenger RNA determines whether the cells depend on Mcl-1 for survival. We further investigated the role of Mcl-1 in NSCLC cells using a Mcl-1-dependent cell line, H23. The expression of a complementary DNA containing only the coding region of MCL1 rescued H23 cells from the toxicity of a 3' untranslated region (UTR) targeting Mcl-1 siRNA but not a siRNA targeting the coding region of MCL1. Furthermore, we show that Mcl-1 sequesters the BH3-only protein Noxa and Bim and the apoptotic effector Bak. Not surprisingly, Noxa, Bim, or Bak knockdown partially rescued H23 cells from toxicity mediated by Mcl-1 siRNA to different degrees. Collectively, our results indicate that targeting Mcl-1 may improve therapy for a subset of NSCLC patients.
Similar articles
- Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.
Qin JZ, Xin H, Sitailo LA, Denning MF, Nickoloff BJ. Qin JZ, et al. Cancer Res. 2006 Oct 1;66(19):9636-45. doi: 10.1158/0008-5472.CAN-06-0747. Cancer Res. 2006. PMID: 17018621 - Non-receptor tyrosine kinase Etk is involved in the apoptosis of small cell lung cancer cells.
Guo L, Chen P, Zhou Y, Sun Y. Guo L, et al. Exp Mol Pathol. 2010 Jun;88(3):401-6. doi: 10.1016/j.yexmp.2010.02.003. Epub 2010 Mar 4. Exp Mol Pathol. 2010. PMID: 20206622 - Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer.
Borner MM, Brousset P, Pfanner-Meyer B, Bacchi M, Vonlanthen S, Hotz MA, Altermatt HJ, Schlaifer D, Reed JC, Betticher DC. Borner MM, et al. Br J Cancer. 1999 Feb;79(5-6):952-8. doi: 10.1038/sj.bjc.6690152. Br J Cancer. 1999. PMID: 10070896 Free PMC article. - Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
Delloye-Bourgeois C, Brambilla E, Coissieux MM, Guenebeaud C, Pedeux R, Firlej V, Cabon F, Brambilla C, Mehlen P, Bernet A. Delloye-Bourgeois C, et al. J Natl Cancer Inst. 2009 Feb 18;101(4):237-47. doi: 10.1093/jnci/djn491. Epub 2009 Feb 10. J Natl Cancer Inst. 2009. PMID: 19211441 - Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.
Varin E, Denoyelle C, Brotin E, Meryet-Figuière M, Giffard F, Abeilard E, Goux D, Gauduchon P, Icard P, Poulain L. Varin E, et al. Carcinogenesis. 2010 Jun;31(6):984-93. doi: 10.1093/carcin/bgq026. Epub 2010 Feb 8. Carcinogenesis. 2010. PMID: 20142415
Cited by
- Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment.
Koirala M, DiPaola M. Koirala M, et al. Biomedicines. 2024 Aug 8;12(8):1801. doi: 10.3390/biomedicines12081801. Biomedicines. 2024. PMID: 39200265 Free PMC article. Review. - PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer.
Shin GC, Lee HM, Kim N, Seo SU, Kim KP, Kim KH. Shin GC, et al. Exp Mol Med. 2024 Feb;56(1):192-209. doi: 10.1038/s12276-023-01147-1. Epub 2024 Jan 10. Exp Mol Med. 2024. PMID: 38200153 Free PMC article. - An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment.
Carrión-Marchante R, Pinto-Díez C, Klett-Mingo JI, Palacios E, Barragán-Usero M, Pérez-Morgado MI, Pascual-Mellado M, Alcalá S, Ruiz-Cañas L, Sainz B Jr, González VM, Martín ME. Carrión-Marchante R, et al. Pharmaceutics. 2023 Apr 18;15(4):1273. doi: 10.3390/pharmaceutics15041273. Pharmaceutics. 2023. PMID: 37111758 Free PMC article. - Novel benzo chromene derivatives: design, synthesis, molecular docking, cell cycle arrest, and apoptosis induction in human acute myeloid leukemia HL-60 cells.
Abd El-Hameed RH, Mohamed MS, Awad SM, Hassan BB, Khodair MAE, Mansour YE. Abd El-Hameed RH, et al. J Enzyme Inhib Med Chem. 2023 Dec;38(1):405-422. doi: 10.1080/14756366.2022.2151592. J Enzyme Inhib Med Chem. 2023. PMID: 36458403 Free PMC article. - Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid Tumors.
Sobol B, Azzam Nieto O, Eberlein EL, Scherr AL, Ismail L, Kessler A, Nader L, Schwab M, Hoffmeister P, Schmitt N, Jäger D, Welte S, Seidensaal K, Christopoulos P, Heilig C, Kriegsmann K, Fröhling S, Kriegsmann M, Hess J, Köhler BC. Sobol B, et al. Int J Mol Sci. 2022 Jul 16;23(14):7850. doi: 10.3390/ijms23147850. Int J Mol Sci. 2022. PMID: 35887198 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials